NASDAQ: UNCYRUSSELL2000
Unicycive Therapeutics, Inc.
Healthcare · Biotechnology · Headquartered in Los Altos, US
Price
Loading chart…
Overview
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.
History & business model
This section is waiting to be written.
InvestWiki is community-edited. Contribute a plain-English history of Unicycive Therapeutics, Inc., its business model, key products, and controversies.